Dilinuer Ainiwaer
Overview
Explore the profile of Dilinuer Ainiwaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsutsue S, Makita S, Asou H, Wada S, Lee W, Ainiwaer D, et al.
PLoS One
. 2025 Feb;
20(2):e0317439.
PMID: 39913543
Diffuse large B-cell lymphoma (DLBCL) is the most prevalent non-Hodgkin lymphoma, with increasing incidence, in Japan. It is associated with substantial economic burden and relatively poor survival outcomes for relapsed/...
2.
Tsutsue S, Makita S, Asou H, Mathew A, Kado Y, Idehara K, et al.
BMC Health Serv Res
. 2025 Jan;
25(1):149.
PMID: 39871251
This study was conducted using a nationwide health care database of Japan between 1 April 2008 and 30 September 2022 to evaluate the economic burden on patients with mantle cell...
3.
Matsumoto T, Yuasa A, Matsuda H, Ainiwaer D, Yonemoto N
Infect Dis Ther
. 2024 Apr;
13(5):1105-1125.
PMID: 38662332
Introduction: Antimicrobial resistance (AMR) is one of the most serious public health challenges worldwide, including in Japan. However, there is limited evidence assessing the AMR burden in Japan. Thus, this...
4.
Kamakura M, Fukuda D, Kuroishi N, Ainiwaer D, Hattori J
AIDS Patient Care STDS
. 2023 Apr;
37(5):253-267.
PMID: 37083443
We conducted a web-based survey targeting physicians in specialties of treating sexually transmitted infection (STI) and/or human immunodeficiency virus (HIV) patients to understand the current STI/HIV care practices and their...
5.
Ueno R, Nishimura S, Fujimoto G, Ainiwaer D
Curr Med Res Opin
. 2021 May;
37(7):1121-1134.
PMID: 33989102
Objective: To examine treatment patterns of real-world antifungal management of patients at high risk of invasive fungal infections (IFI) and evaluate healthcare resource utilization and costs associated with antifungal management...
6.
Fujii T, Kidoguchi Y, Takahashi N, Yu E, Ainiwaer D, Byrne A
J Med Econ
. 2021 Jan;
24(1):218-225.
PMID: 33459088
Objective: Hemophilia A (HA) is a genetic bleeding disorder characterized by a deficiency of clotting factor VIII (FVIII) requiring lifelong prophylactic treatment typically with conventional standard half-life recombinant FVIII (rFVIII)....
7.
Ueno R, Nishimura S, Fujimoto G, Ainiwaer D
Curr Med Res Opin
. 2020 Nov;
37(2):253-260.
PMID: 33143482
Objective: To evaluate outcomes, healthcare resource utilization, and costs associated with mucormycosis in inpatient settings in Japan. Methods: We performed a systematic literature review, followed by a retrospective database study...